SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

PURPOSE: The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or gallbladder carcinoma (GBCA) is unknown. S0809 was designed to estimate 2-year survival (overall and after R0 or R1 resection), pattern of relapse, and toxicity in patients treated with this adjuvant regimen. PAT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Ben-Josef, Edgar, Guthrie, Katherine A., El-Khoueiry, Anthony B., Corless, Christopher L., Zalupski, Mark M., Lowy, Andrew M., Thomas, Charles R., Alberts, Steven R., Dawson, Laura A., Micetich, Kenneth C., Thomas, Melanie B., Siegel, Abby B., Blanke, Charles D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534524/
https://ncbi.nlm.nih.gov/pubmed/25964250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.60.2219
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados